-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Lisaftoclax in Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Lisaftoclax in Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Lisaftoclax in Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) Drug Details: Lisaftoclax (APG...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – OCE-205 in Ascites
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - OCE-205 in Ascites report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. OCE-205 in Ascites Drug Details: OCE-205 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – OCE-205 in Hepatorenal Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - OCE-205 in Hepatorenal Syndrome report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. OCE-205 in Hepatorenal Syndrome Drug Details: OCE-205 is under development for the...
-
Product Insights
Ascites – Drugs In Development, 2023
Global Markets Direct’s, ‘Ascites - Drugs In Development, 2023’, provides an overview of the Ascites pipeline landscape. The report provides comprehensive information on the therapeutics under development for Ascites, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – OCE-205 in Hepatorenal Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - OCE-205 in Hepatorenal Syndrome report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.OCE-205 in Hepatorenal Syndrome Drug Details:OCE-205 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NUV-655 in Diffuse Large B-Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NUV-655 in Diffuse Large B-Cell Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.NUV-655 in Diffuse Large B-Cell Lymphoma Drug Details:NUV-655 is under development...
-
Product Insights
Ocelote Field, Colombia
Ocelote Field is a producing field located in Meta, Colombia. It is being operated by Hocol SA. Empower your strategies with our Ocelote Field, Colombia report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to...
-
Company Profile
General Dynamics Land Systems Inc – Company Profile
General Dynamics Land Systems Inc (GDLS), a business unit of General Dynamics Corp, designs, develops, manufactures and sells a wide range of tracked and wheeled military vehicles. The company’s product portfolio includes main battle tanks, Stryker combat vehicles, light armored vehicles, Stryker wheeled vehicles, specialty vehicles, weapon systems and robotics systems. It also provides supply support, field support and training support services. The company primarily serves the US Army, military and other governments. It sells its products under various brands,...
Add to Basket -
Company Profile
Avinger Inc – Company Profile
Avinger Inc (Avinger) designs, manufactures and sells image-guided, catheter-based systems to treat patients with peripheral artery disease (PAD). It develops products based on its Lumivascular platform, an intravascular image-guided system that provides real-time visualization of the inside of the artery during PAD treatment by using optical coherence tomography (OCT). The company’s product portfolio includes Lightbox imaging console, the Ocelot family of catheters and Pantheris, an image-guided atherectomy device. Avinger sells a suite of products in the US and selected international...
Add to Basket -
Product Insights
Avinger Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Avinger Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Avinger Inc (Avinger) designs, manufactures and sells image-guided, catheter-based systems to treat patients with peripheral artery disease (PAD). It develops products based on its Lumivascular platform, an intravascular image-guided system that provides real-time visualization of the inside of the artery during PAD treatment by using optical coherence tomography (OCT). The company’s product portfolio includes Lightbox imaging console, the Ocelot family...